Hypothyroidism

Endocrinology·MeSH: Hypothyroidism

Prevalence

30.0 / 100K

10 drugs in development·6 companies·3 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
ermeza	Mylan II B.V. (MYL)
UNITHROID	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 2(5)

Drug	Company
Levothyroxine	Crinetics Pharmaceuticals, Inc. (CRNX)
levothyroxine sodium	Xeris Biopharma Holdings, Inc. (XERS)
North Star	Crinetics Pharmaceuticals, Inc. (CRNX)
North Star	ENANTA PHARMACEUTICALS INC (ENTA)
XP-8121	Xeris Biopharma Holdings, Inc. (XERS)

Unknown(1)

Drug	Company
Synthroid™	ABBOTT LABORATORIES (ABT)

Phase 4(2)

Drug	Company
Levothyroxine	ENANTA PHARMACEUTICALS INC (ENTA)
Levothyroxine Sodium	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 10 drugs in development for Hypothyroidism across 6 companies.

There are 3 clinical trials targeting Hypothyroidism tracked by BioSniper.

The estimated prevalence of Hypothyroidism is approximately 30.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.